Errata,
R&D's aren't valued on earnings multiples.
Valuation is based on intangibles like patents, reputation/perception, know how and human capability/skillsets. This is weighed against market size of target(s) and revenue/earnings potential.
I can show you companies that haven't sold a plug nickel and don't have a product in the marketplace with market valuations into the billions. Biotech and health have been hot for couple years now ... yet Dahl is still begging for money. So what's the problem ?
As to sellers .... what did Dahl shareholder message impart to you ??? Things are great and we're moving ahead ???? .... or I can't do anything without more money ? People are returning our calls now but we'll let ya know when things happen ..... What if anything did he say that would inspire someone to buy and make a seller think twice about unloading stock ?
I would bet that 10 cents is key to funding ..... just sayin'. Dahl doesn't get the importance of stock price. I wouldn't say buyers are coming out of the woodwork at .10. I mean what ..... $11,000 traded today thus far ? That is nothing.
Diluted market value is about $20 mil.
Funny thing too .... way back .... Dahl was asked about gov't grants and the like .... as gov't was handing out plenty of money for algae research. Answer was it took too long ..... to much process. Example of shortsightedness. Must explore all avenues to access funding especially those that are FREE. I believe can also get a loan from the gov't as well. Probably could have gotten a gov't grant by now. Just another way to reduce dilution potential .....
The market value of a bioactive that is natural and effective against bovine mastitis and its various originating pathogens itself has global application and a multibillion dollar market size. If ZIVO were to capture just 5% of the global market potential between feed and therapeutic, that would likely be in excess of $100 million annually in revenues were they to do it alone.
The model is to license to companies that can .... use other people's money and sit back and collect the royalties or whatever agreed upon cut. Enough licenses and the company could easily be a cash machine as there wouldn't be a need for large staff.
But again, what does one get from Dahl's message ??
Amigo Mike
News 
Market Data 
Discover 
